| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|---|
Phase N/A 1
2 3 4 Trials | | 0 | 5101520253035404550 |
|---|
| | | | |
|---|
| | | | |
|---|
| | | | |
|---|
| Zokinvy (lonafarnib) / Eiger | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| Naglazyme (galsulfase) / AnGes MG, BioMarin | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| Allovectin-7 (velimogene aliplasmid) / AnGes MG, Fresh Tracks Therap | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| Collategene (beperminogene perplasmid) / AnGes MG, Mitsubishi Tanabe | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| AG0302-COVID19 / Takara, AnGes MG, Osaka University Graduate School of Medicine | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| AV-001 / Vasomune Therap, AnGes MG | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| GEN0101 / AnGes MG, TSD Japan | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| AG0301-COVID19 / Takara, AnGes MG, Osaka University Graduate School of Medicine, Fresh Tracks Therap | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| NF-kappa-B Decoy oligonucleotide topical (AMG0101 topical) / AnGes MG, Shionogi | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| cupabimod (AMG0103) / AnGes MG, Shionogi | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
|
